title: Relation between cytoskeleton, hypo-osmotic treatment and volume regulation in Ehrlich ascites tumor cells.
abstract: Pretreatment with cytochalasin B, which is known to disrupt microfilaments, significantly inhibits regulatory volume decrease (RVD) in Ehrlich ascites tumor cells, suggesting that an intact microfilament network is a prerequisite for a normal RVD response. Colchicine, which is known to disrupt microtubules, has no significant effect on RVD. Ehrlich cells have a cortical three-dimensional, orthogonal F-actin filament network which makes the cells look completely black in light microscopy following immunogold/silver staining using anti-actin antibodies. After addition of cytochalasin B, the stained cells get lighter with black dots localized to the plasma membrane and appearance of multiple knobby protrusions at cell periphery. Also, a significant decrease in the staining of the cells is seen after 15 min of RVD in hypotonic medium. This microfilament reorganization appears during RVD in the presence of external Ca2+ or Ca(2+)-ionophore A23187. It is, however, abolished in the absence of extracellular calcium, with or without prior depletion of intracellular Ca2+ stores. An effect of increased calcium influx might therefore be considered. The microfilament reorganization during RVD is abolished by the calmodulin antagonists pimozide and trifluoperazine, suggesting the involvement of calmodulin in the process. The microfilament reorganization is also prevented by addition of quinine. This quinine inhibition is overcome by addition of the K+ ionophore valinomycin.
authors.affiliation: Laboratory of Cell and Tissue Biology, University of Liège, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Cornet
authors.forename: I H
authors.initials: IH
authors.lastname: Lambert
authors.forename: E K
authors.initials: EK
authors.lastname: Hoffmann
mesh_terms: D008841:Actin Cytoskeleton / Q000187:drug effects / Q000473:pathology; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000473:pathology*; D003571:Cytochalasin B / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects / Q000473:pathology*; D005260:Female; D007038:Hypotonic Solutions; D066298:In Vitro Techniques; D051379:Mice; D009997:Osmotic Pressure
chemical_list: D007038:Hypotonic Solutions; D000001:Calcimycin; D003571:Cytochalasin B; D002118:Calcium